According to a report by Tobacco Reporter on November 7, The Wall Street Journal stated that tobacco stock prices increased after United States President Donald Trump's election victory.
Today (7th), British American Tobacco (BAT) stock rose by 4%. Its subsidiary, Reynolds Tobacco (Reynolds American), was a major donor to the "Make America Great Again" Committee, which supported former President Trump's reelection campaign.
Reynolds Tobacco has been resisting the proposed mint flavor ban from the Biden administration, which was delayed earlier this year. It is estimated that under the leadership of the Trump administration, the mint flavor ban could be completely overturned.
British American Tobacco (BAT), Altria, and Imperial Brands (IMB) all have significant operations in the American mint cigarette market, with these products accounting for over a third of the total volume of the US cigarette market.
Additionally, the re-elected Trump administration may continue to crack down on the illegal importation of disposable e-cigarettes from China. During his first term as president, Trump actively implemented barriers on imported goods from China, a move that could potentially benefit some tobacco companies' e-cigarette brands.
However, the expected strengthening of the US dollar during Trump's presidency could be troublesome for Philip Morris International (PMI) as around 90% of the multinational company's sales come from currencies of other mainly emerging markets. Inflation may also rise, impacting tobacco stocks as they primarily target price-sensitive low-income consumers.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
